Camp4 Therapeutics Corp

Penny Stocks Biotech Stocks Healthcare Stocks

$4.46

+0.12 (+2.77%)

As of May 16, 2:06 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 83%

Hold 2 17%

Sell 0 0%

Price Target

Analyst Price Target +169.3% upside

Low Target $8.14

Average Target $12.01

High Target $13.09

Current Price $4.46

Current
$4.46

Target
$12.01

$8.14 $12.01 avg $13.09

Scenario Analysis

Bear Case

$8.14

82.5%

Low target

Base Case

$12.01

+169.3%

Avg target

Bull Case

$13.09

+193.5%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$7.75

-42.5% from high

52-Week Low

$1.31

+241.8% from low

Target vs 52W High

$12.01

+55.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%